Toggle light / dark theme

For people with advanced kidney cancer, an injectable form of nivolumab (Opdivo) is a suitable alternative to the original intravenous form, early results from a clinical trial have shown. Experts say the injectable form makes the treatment quicker and easier for patients to receive.

As a result, “patients’ treatment experience will be significantly improved,” said the trial’s leader, Saby George, M.D., of Roswell Park Comprehensive Cancer Center in Buffalo, NY.

The clinical trial involved nearly 500 people with advanced or metastatic kidney cancer. All participants were randomly assigned to receive a new form of nivolumab that is given as injection under the skin (subcutaneous) or the original form, which is given through a vein (an intravenous infusion, or IV).

However, the White House Office of Management and Budget said in a statement of policy on Tuesday: “The Administration strongly opposes Section 924, which would establish a Drone Corps as a basic branch of the Army. A Drone Corps would create an unwarranted degree of specialization and limit flexibility to employ evolving capabilities. Further, the Secretary of the Army already has the authority to create branches, as needed, and creating a branch through legislation would detract from the Army’s flexibility in addressing current and future requirements.” The statement included a list of concerns about various items in the House version of the NDAA that it finds objectionable.

Senior Army officers have also come out against the proposal.